Flu Vaccine (Influenza Vaccine) Market Report

Europe Flu Vaccine (Influenza Vaccine) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 18, 2020
  • PAGES：230
  • REPORT CODE：GMM550568
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Flu Vaccine (Influenza Vaccine) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 17.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Flu Vaccine (Influenza Vaccine) Market Segmentations:

    By Player:

    • GSK

    • CSL

    • AstraZeneca

    • Mylan

    • Sanofi Pasteur

    • Pfizer

    • Johnson & Johnson

    By Type:

    • Whole Virus Vaccines

    • Split Virus Vaccines

    • Subunit Vaccines

    • Live Attenuated Virus Vaccines

    By End-User:

    • For Children (6 months to 3 years)

    • For Adults and Children over 3 years

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Flu Vaccine (Influenza Vaccine) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Whole Virus Vaccines from 2014 to 2026

    • 1.3.2 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Split Virus Vaccines from 2014 to 2026

    • 1.3.3 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Subunit Vaccines from 2014 to 2026

    • 1.3.4 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Live Attenuated Virus Vaccines from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Children (6 months to 3 years) from 2014 to 2026

    • 1.4.2 Europe Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Adults and Children over 3 years from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Flu Vaccine (Influenza Vaccine) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Flu Vaccine (Influenza Vaccine) by Major Types

      • 3.4.1 Market Size and Growth Rate of Whole Virus Vaccines

      • 3.4.2 Market Size and Growth Rate of Split Virus Vaccines

      • 3.4.3 Market Size and Growth Rate of Subunit Vaccines

      • 3.4.4 Market Size and Growth Rate of Live Attenuated Virus Vaccines

    4 Segmentation of Flu Vaccine (Influenza Vaccine) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Flu Vaccine (Influenza Vaccine) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of For Children (6 months to 3 years) for Construction

      • 4.4.2 Market Size and Growth Rate of For Adults and Children over 3 years for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Flu Vaccine (Influenza Vaccine) Production Analysis by Top Regions

    • 5.2 Europe Flu Vaccine (Influenza Vaccine) Consumption Analysis by Top Regions

    • 5.3 Europe Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Flu Vaccine (Influenza Vaccine) Market among Top Countries

    • 6.1 Top 5 Export Countries in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 7.1 Germany Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 7.2 Germany Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    8. UK Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 8.1 UK Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 8.2 UK Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    9. France Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 9.1 France Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 9.2 France Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    10. Italy Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 10.1 Italy Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 10.2 Italy Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    11. Spain Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 11.1 Spain Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 11.2 Spain Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    12. Poland Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 12.1 Poland Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 12.2 Poland Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    13. Russia Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 13.1 Russia Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 13.2 Russia Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    14. Switzerland Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 14.1 Switzerland Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 14.2 Switzerland Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    15. Turkey Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 15.1 Turkey Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 15.2 Turkey Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 16.3.2 Finland Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 16.3.3 Norway Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 16.3.4 Sweden Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 16.3.6 Iceland Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 17.3.2 Netherlands Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 18.3.2 Latvia Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

      • 18.3.3 Lithuania Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GSK

      • 19.1.1 GSK Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 CSL

      • 19.2.1 CSL Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 AstraZeneca

      • 19.3.1 AstraZeneca Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Mylan

      • 19.4.1 Mylan Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Sanofi Pasteur

      • 19.5.1 Sanofi Pasteur Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pfizer

      • 19.6.1 Pfizer Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Johnson & Johnson

      • 19.7.1 Johnson & Johnson Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 94 Figures and 163 Tables)

    • Figure Product Picture

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Whole Virus Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Split Virus Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Subunit Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Live Attenuated Virus Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Children (6 months to 3 years) from 2014 to 2026

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Adults and Children over 3 years from 2014 to 2026

    • Figure Germany Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure France Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Flu Vaccine (Influenza Vaccine) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Flu Vaccine (Influenza Vaccine)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Flu Vaccine (Influenza Vaccine) by Different Types from 2014 to 2026

    • Table Consumption Share of Flu Vaccine (Influenza Vaccine) by Different Types from 2014 to 2026

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Whole Virus Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Split Virus Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Subunit Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of Live Attenuated Virus Vaccines Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Flu Vaccine (Influenza Vaccine) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Flu Vaccine (Influenza Vaccine) by Different End-Users from 2014 to 2026

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Children (6 months to 3 years) from 2014 to 2026

    • Figure Flu Vaccine (Influenza Vaccine) Market Size and Growth Rate of For Adults and Children over 3 years from 2014 to 2026

    • Table Europe Flu Vaccine (Influenza Vaccine) Production by Major Regions

    • Table Europe Flu Vaccine (Influenza Vaccine) Production Share by Major Regions

    • Figure Europe Flu Vaccine (Influenza Vaccine) Production Share by Major Countries and Regions in 2014

    • Table Europe Flu Vaccine (Influenza Vaccine) Consumption by Major Regions

    • Table Europe Flu Vaccine (Influenza Vaccine) Consumption Share by Major Regions

    • Table Germany Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table UK Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table France Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Italy Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Spain Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Poland Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Russia Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Switzerland Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Turkey Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Flu Vaccine (Influenza Vaccine) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Germany Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Germany Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Germany Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table UK Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table UK Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table UK Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table UK Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table France Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table France Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table France Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table France Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Italy Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Italy Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Italy Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Spain Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Spain Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Spain Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Poland Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Poland Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Poland Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Russia Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Russia Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Russia Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Switzerland Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Turkey Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Turkey Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Turkey Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Flu Vaccine (Influenza Vaccine) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Flu Vaccine (Influenza Vaccine) Market Volume and Growth Rate from 2014 to 2026

    • Table GSK Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table GSK Product benchmarking

    • Table GSK Strategic initiatives

    • Table GSK SWOT analysis

    • Table CSL Profiles

    • Table CSL Production, Value, Price, Gross Margin 2014-2019

    • Table CSL Product benchmarking

    • Table CSL Strategic initiatives

    • Table CSL SWOT analysis

    • Table AstraZeneca Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table AstraZeneca Product benchmarking

    • Table AstraZeneca Strategic initiatives

    • Table AstraZeneca SWOT analysis

    • Table Mylan Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Mylan Product benchmarking

    • Table Mylan Strategic initiatives

    • Table Mylan SWOT analysis

    • Table Sanofi Pasteur Profiles

    • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Pasteur Product benchmarking

    • Table Sanofi Pasteur Strategic initiatives

    • Table Sanofi Pasteur SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Johnson & Johnson Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Product benchmarking

    • Table Johnson & Johnson Strategic initiatives

    • Table Johnson & Johnson SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US